Point mutations in the DNA- and cNMP-binding domains of the homologue of the cAMP receptor protein (CRP) in Mycobacterium bovis BCG: implications for the inactivation of a global regulator and strain attenuation
The genome of Mycobacterium tuberculosis H37Rv includes a homologue of the CRP/FNR (cAMP receptor protein/fumarate and nitrate reduction regulator) family of transcription regulators encoded by Rv3676. Sequencing of the orthologous gene from attenuated Mycobacterium bovis Bacille Calmette–Guérin (BCG) strains revealed point mutations that affect the putative DNA-binding and cNMP-binding domains of the encoded protein. These mutations are not present in the published sequences of the Rv3676 orthologues in M. bovis, M. tuberculosis or Mycobacterium leprae. An Escherichia coli lacZ reporter system was used to show that the M. tuberculosis Rv3676 protein binds to DNA sites for CRP, but this DNA binding was decreased or abolished with the Rv3676 protein counterparts from BCG strains. The DNA-binding ability of the M. tuberculosis Rv3676 protein was decreased by the introduction of base changes corresponding to the BCG point mutations. Conversely, the DNA binding of the BCG Rv3676 proteins from BCG strains was restored by removing the mutations. These data show that in this reporter system the point mutations present in the Rv3676 orthologue in BCG strains render its function defective (early strains) or abolished (late strains) and suggest that this protein might be naturally defective in M. bovis BCG strains. This raises the possibility that a contributing factor to the attenuation of BCG strains may be an inability of this global regulator to control the expression of genes required for in vivo survival and persistence.
AltschulS. F.,
MaddenT. L.,
SchafferA. A.,
ZhangJ.,
ZhangZ.,
MillerW.,
LipmanD. J.
1997; Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402[CrossRef]
BehrM. A.,
WilsonM. A.,
GillW. P.,
SalamonH.,
SchoolnikG. K.,
RaneS.,
SmallP. M.
1999; Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520–1523[CrossRef]
BehrM. A.,
SchroederB. G.,
BrinkmanJ. N.,
SlaydenR. A.,
BarryC. E.III2000; A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927. J Bacteriol 182:3394–3399[CrossRef]
BellA.,
BusbyS.
1994; Location and orientation of an activating region in the Escherichia coli transcription factor, FNR. Mol Microbiol 11:383–390[CrossRef]
BellA. I.,
GastonK. L.,
ColeJ. A.,
BusbyS. J.
1989; Cloning of binding sequences for the Escherichia coli transcription activators, FNR and CRP: location of bases involved in discrimination between FNR and CRP. Nucleic Acids Res 17:3865–3874[CrossRef]
BellA.,
GastonK.,
WilliamsR.,
ChapmanK.,
KolbA.,
BucH.,
MinchinS.,
WilliamsJ.,
BusbyS.
1990; Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription. Nucleic Acids Res 18:7243–7250[CrossRef]
BettsJ. C.,
LukeyP. T.,
RobbL. C.,
McAdamR. A.,
DuncanK.
2002; Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43:717–731[CrossRef]
BusbyS.,
KolbA.
1996; The CAP modulon. In Regulation of Gene Expression in Escherichia coli pp 255–279 Edited by
LinE. C. C.,
LynchA. S.
Georgetown, TX: R. G. Landes Company;
ChouP. Y.,
FasmanG. D.
1974; Conformational parameters for amino acids in helical, β-sheet, and random coil regions calculated from proteins. Biochemistry 13:211–222[CrossRef]
ColeS. T.,
BroschR.,
ParkhillJ.
& 39 other authors; 1998; Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537–544erratum, 396, 190[CrossRef]
FleischmannR. D.,
AllandD.,
EisenJ. A.
& 23 other authors; 2002; Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol 184:5479–5490[CrossRef]
GaltierN.,
GouyM.,
GautierC.
1996; seaview and phylo_win: two graphic tools for sequence alignment and molecular phylogeny. Comput Appl Biosci 12:543–548
GarnierT.,
EiglmeierK.,
CamusJ. C.
& 19 other authors; 2003; The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A 100:7877–7882[CrossRef]
GlickmanM. S.,
CoxJ. S.,
JacobsW. R.Jr2000; A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell 5:717–727[CrossRef]
GreenJ.,
ScottC.,
GuestJ. R.
2001; Functional versatility in the CRP-FNR superfamily of transcription factors: FNR and FLP. Adv Microbiol Physiol 44:1–34
GuérinC.,
RosenthalS. R.
1957; The history of BCG: early history. In BCG Vaccination Against Tuberculosis, pp 48–57 Edited by
RosenthalS. R.
London: Churchill;
JayaramanP. S.,
ColeJ. A.,
BusbyS. J.
1989; Mutational analysis of the nucleotide sequence at the FNR-dependent nirB promoter in Escherichia coli
. Nucleic Acids Res 17:135–145[CrossRef]
KimH.-J.,
KimT.-H.,
KimY.,
LeeH.-S.
2004; Identification and characterization of glxR, a gene involved in regulation of glyoxylate bypass in Corynebacterium glutamicum
. J Bacteriol 186:3453–3460[CrossRef]
LissendenS.,
MohanS.,
OvertonT.
& 9 other authors; 2000; Identification of transcriptional activators that regulate gonococcal adaptation from aerobic to anaerobic or oxygen-limited growth. Mol Microbiol 37:839–855[CrossRef]
LodgeJ.,
FearJ.,
BusbyS.,
GunasekaranP.,
KaminiN. R.
1992; Broad host range plasmids carrying the Escherichia coli lactose and galactose operons. FEMS Microbiol Lett 95:271–276[CrossRef]
MattowJ.,
JungblutP. R.,
SchaibleU. E.,
MollenkopfH.-J.,
LamerS.,
Zimny-ArndtU.,
HagensK.,
KaufmannS. H. E, MüllerE.-C.2001; Identification of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains. Electrophoresis 22:2936–2946[CrossRef]
McKinneyJ. D.,
Honer zu BentrupK.,
Munoz-EliasE. J.
& 9 other authors; 2000; Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735–738[CrossRef]
MukamolovaG. V.,
TurapovO. A.,
YoungD. I.,
KaprelyantsA. S.,
KellD. B.,
YoungM.
2002; A family of autocrine growth factors in Mycobacterium tuberculosis. Mol Microbiol 46:623–635[CrossRef]
PymA. S.,
BrodinP.,
BroschR.,
HuerreM.,
ColeS. T.
2002; Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.. Mol Microbiol 46:709–717[CrossRef]
SpiroS.,
GuestJ. R.
1988; Inactivation of the FNR protein of Escherichia coli by targeted mutagenesis in the N-terminal region. Mol Microbiol 2:701–707[CrossRef]
van SoolingenD.,
HermansP. W. M., de HaasP. E. W.,
SollD. R,
van EmbdenJ. D. A.
1991; Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 29:2578–2586
Point mutations in the DNA- and cNMP-binding domains of the homologue of the cAMP receptor protein (CRP) in Mycobacterium bovis BCG: implications for the inactivation of a global regulator and strain attenuation